Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hybridon and Aegera collaborate to develop antisense drug targeting XIAP gene

Sep. 23, 2002

Access Oncology obtains rights to develop and market antitumor alkylphosphocholine

Sep. 23, 2002

New data on the antiangiogenic effects of endostatin against advanced solid tumors

Sep. 23, 2002

Favorable pharmacokinetic profile described for new camptothecin analogue DRF-1042

Sep. 23, 2002

Pfizer returns rights to Onyx products

Sep. 20, 2002

Copper chelator exerts antiangiogenic effects via suppression of NF-kB activity

Sep. 20, 2002

AP-23675 discovered for primary bone cancers and bone metastases

Sep. 20, 2002

Progen licenses preclinical cancer therapy from Unisearch

Sep. 20, 2002

MX-8899 evaluated in new radiation-induced dermatitis trial

Sep. 19, 2002

New anticancer product candidate at Ariad

Sep. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...